Back to the feed
In brief
On 30.10.2026, a person holding the function "Executive member of the board of directors / senior management" at PolyPeptide Group AG disclosed a sale worth CHF 6’321’929 to SIX Exchange Regulation.
By amount, this ranks #2 of 12 management sales disclosed at PolyPeptide Group AG over the previous 12 months.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of PolyPeptide Group AG declared a "Sale" transaction on 30.10.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date30.10.2026
Issuing companyPolyPeptide Group AG
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeOther securities
SecurityPerformance Share Unit (PSU) granted under the
PolyPeptide Group AG Long Term Incentive Plan
(LTIP). PSUs represent the contingent right to
receive a certain number of registered shares of
PolyPeptide Group AG (PPGN; CH1110760852) in the
future, provided that certain performance and
other conditions are achieved. The (regular)
vesting of (i) 30% of the granted PSUs is based on
the cumulative revenue, (ii) 40% of the granted
PSUs is based on the cumulative EBITDA, and (iii)
30% of the granted PSUs is based on Total
Shareholder Return (TSR), in each case as achieved
during the three-year performance period compared
to pre-defined performance ranges with minimum,
target and maximum (200%) performance goals,
subject to an absolute value cap representing 500%
of the original grant award. In the event of a
change of control, PSUs immediately vest at target
upon such change of control.
Quantity142’675
Unit priceCHF 44.31
AmountCHF 6’321’929
ConditionsEnd of the additional acceptance period
(Nachfrist) of the public tender offer of Samsung
Peptide AG: 30 October 2026. The settlement of the
offer will constitute a change of control under
the LTIP. This notification assumes that the PSUs
will vest at target upon settlement of the offer.
Subject to the settlement of the offer, the PSUs
will be settled in cash, at a value per share to
which the holder would be entitled under the PSUs
equal to the offer price.
ExchangeXSWX
Notification IDT1QAU000A9
Other PolyPeptide Group AG insider transactions
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 10’095’679
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 156’769
- Sale · Non-executive member of the board of directors30.10.2026CHF 141’819
- Sale · Non-executive member of the board of directors30.10.2026CHF 190’090
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 296’301
These figures aggregate public disclosures. They are not investment advice.